相关实验视频
Updated: Jul 5, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
风险子组和干预效应在婴儿中高风险的花生过敏:临床决策的模型
Yuxiang Li1,2, Ashley Devonshire3,4, Bin Huang1,3
1Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
概括
早期引入花生可以显著降低婴儿过敏的风险. 风险较高的婴儿经历了更大的绝对风险降低,为个性化过敏预防策略提供了信息.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 儿科医学 儿科医学
- 计算生物学 计算生物学
背景情况:
- 关于花生过敏的早期学习 (LEAP) 试验表明,早期引入花生可以降低高风险婴儿的过敏风险.
- 这次二次分析的目的是确定花生过敏的婴儿特定风险子组.
- 该研究还估计了这些子组中早期引入花生的干预效应.
研究的目的:
- 确定婴儿中花生过敏发展的不同风险子组.
- 量化早期引入花生在这些已识别的风险小组中的有效性.
- 为个性化风险评估和预防花生过敏的临床决策提供数据.
主要方法:
- 利用了LEAP试验数据,从ITNTrialShare.org.org.org获取原始数据.
- 应用条件随机森林和分类和回归树 (CART) 分析到基线数据 (4-11个月).
- 估计的干预效应通过比较花生引入与避免跨风险亚组的武器,调整IgE水平.
主要成果:
- 预测花生过敏概率较高的婴儿从早期引入中显示出相似的相对但更大的绝对风险降低.
- 基线花生特异性IgE (sIgE) ≥0.22kU/L的参与者在绝对风险降低了40.4%.
- 低SIGE (<0.22 kU/L) 和低Ara h 2 sIgE (<0.10 kU/L) 的婴儿的绝对风险降低了6.5%.
结论:
- 在LEAP队列中确定了花生过敏的风险亚组.
- 早期引入花生表明,在所有已识别的风险亚组中都有显著的干预效应.
- 研究结果支持基于个体风险评估的个性化方法来预防花生过敏.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Hazard Ratio
128
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
128
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Relative Risk
174
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
174
Strategies for Assessing and Addressing Confounding
101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101

